Open AccessMALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS– A COMPLICATION OF TAMOXIFEN THERAPY FOR BREAST CARCINOMA
Author(s) -
Surekha Tayade,
Naina Kumar
Publication year - 2012
Publication title -
international journal of biomedical and advance research
Language(s) - English
Resource type - Journals
eISSN - 2455-0558
pISSN - 2229-3809
DOI - 10.7439/ijbar.v3i5.474
Subject(s) - tamoxifen , medicine , uterus , radiation therapy , breast cancer , endometrium , cancer , oncology , endometrial cancer , carcinoma , uterine cancer , adjuvant therapy , gynecology
Patients with breast cancer exhibit an increased risk in developing neoplasms of other organs. In case of endometrium, the increased risk might be due to tamoxifen adjuvant therapy and prior radiotherapy. Carcinosarcomas are rare uterine cancers and carry poor prognosis. We present a case of Malignant Mixed Mullerian Tumor (MMMT) of the uterus in a 46-year-old woman, after tamoxifen treatment and radiotherapy for breast cancer. We emphasise that postmenopausal women taking tamoxifen should be monitored closely for symptoms of endometrial lesions.